ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999